Kinsight LLC’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Kinsight LLC’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$51K	Hold	107	–	–	0.03%	32
2017 Q1	$80K	Hold	107	–	–	0.04%	35
2016 Q4	$104K	Hold	107	–	–	0.05%	35
2016 Q3	$142K	Hold	107	–	–	0.08%	36
2016 Q2	$93K	Hold	107	–	–	0.05%	35
2016 Q1	$149K	Hold	107	–	–	0.09%	32
2015 Q4	$197K	Buy	107 +57	+114%	+$114K	0.11%	33
2015 Q3	$98K	Buy	+50	New	+$117K	0.07%	31

Other funds holding TCON

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Kinsight LLC's TCON Position: Q2 2017 in Review

Kinsight LLC held its TRACON Pharmaceuticals, Inc. Common Stock (TCON) position steady in Q2 2017 at 107 shares worth $51K. The position accounts for 0.03% of the portfolio, ranked #32.

Kinsight LLC first reported a position in TCON in Q3 2015 and has held it in 8 quarters since. The position peaked at $197K in Q4 2015. 26 funds tracked by Wall St. Rank hold TCON as of Q2 2017.

Kinsight LLC held 107 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $51K as of Q2 2017.
Kinsight LLC left its TRACON Pharmaceuticals, Inc. Common Stock share count unchanged in Q2 2017.
TRACON Pharmaceuticals, Inc. Common Stock made up 0.03% of Kinsight LLC's portfolio in Q2 2017, its #32 holding.
Kinsight LLC first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2015 and has held it in 8 quarters since.
Kinsight LLC's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $197K in Q4 2015.
26 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2017.

Based on Kinsight LLC's 13F filing for Q2 2017, filed 24 Jul 2017.